NCT07316803 Group Intervention for Romantic Relationships in Young Adults With Severe Mental Illness Status RECRUITING Phase NA
NCT07276997 A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder Status RECRUITING Phase PHASE2
NCT07273851 Comparison of Propofol and Ketofol as Induction Agents for Electroconvulsive Therapy Status COMPLETED Phase NA
NCT07262008 Sustained Mood Improvement With Laughing Gas Exposure Status NOT_YET_RECRUITING Phase PHASE3
NCT07253324 ENX-104 MAD Study for Participants With Major Depressive Disorder With Anhedonia (aMDD) Status COMPLETED Phase PHASE1
NCT07204314 A Study of Vortioxetine in Japanese Pediatric Patients With Major Depressive Disorder Status RECRUITING Phase PHASE3
NCT07196501 A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD) Status RECRUITING Phase PHASE3
NCT07185815 Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine Depot) in Subjects Eligible for Treatment With Oral Cariprazine Status RECRUITING Phase PHASE1/PHASE2
NCT07180342 An Empirical Study on the Mechanisms of Biopsychosocial Functional Improvement in Patients With Major Depressive Disorder Through Nature-Based Tourism Activities Status RECRUITING Phase NA
NCT07174557 Remote Evaluation and Alerting for Collaborative Health (REACH) in Depression Status NOT_YET_RECRUITING Phase NA
NCT07136714 Does Semaglutide Improve Depressive Symptoms in Patients With Major Depressive Disorder and Overweight or Obesity Status RECRUITING Phase PHASE4
NCT07115329 A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder Status RECRUITING Phase PHASE2
NCT07111390 Feasibility of Home-Based Intermittent 60Hz Light Therapy for Major Depressive Disorder (MDD) Status RECRUITING Phase NA
NCT07105111 A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor Status RECRUITING Phase PHASE4